Replies to post #617541 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

I doubt there’s much cash flow from specials over the last quarter. But we’ll see very shortly. The company’s cash burn is well over $1 million per week (~ $13 million per quarter). So there has to be a significant source of revenue and cash flow to cover (or net out) that short fall.

Did they ramp up almost over night to fund that gap?